Extracellular signal-regulated kinases

Protein family involved in cellular signal transduction

Extracellular signal-regulated kinases (ERKs) are a group of protein-serine/threonine kinases that are activated by a variety of extracellular signals. They are part of the mitogen-activated protein kinase (MAPK) pathway, which plays a crucial role in the regulation of various cellular processes, including cell proliferation, differentiation, and survival.

Structure and Function

ERKs are typically activated through a phosphorylation cascade initiated by the binding of growth factors, hormones, or other signaling molecules to cell surface receptors. This activation leads to the phosphorylation of ERKs by upstream kinases, such as MAP kinase kinase (MEK). Once activated, ERKs translocate to the cell nucleus, where they phosphorylate various nuclear targets, including transcription factors, thereby influencing gene expression.

Types of ERKs

The ERK family consists of several isoforms, with ERK1 and ERK2 being the most studied. These isoforms share significant sequence homology and are often referred to collectively as ERK1/2. Other members of the ERK family include ERK3, ERK4, ERK5, and ERK7, each with distinct regulatory mechanisms and functions.

Role in Disease

Dysregulation of ERK signaling has been implicated in various diseases, particularly cancer. Overactivation of ERK pathways can lead to uncontrolled cell growth and proliferation, contributing to tumorigenesis. Inhibitors targeting components of the ERK pathway are being developed as potential therapeutic agents for cancer treatment.

Research and Clinical Implications

Research on ERKs continues to uncover their roles in different cellular contexts and their potential as targets for therapeutic intervention. Understanding the precise mechanisms of ERK activation and function is crucial for developing effective treatments for diseases associated with ERK dysregulation.

Related Pages

• Mitogen-activated protein kinase
• Cell signaling
• Protein kinase
• Transcription factor
• Cell proliferation
• Cancer